{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T06:28:15Z","timestamp":1757312895401,"version":"3.30.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Ningbo Medical Science and Technology Project","award":["2018A64"],"award-info":[{"award-number":["2018A64"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-024-02180-0","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T02:59:24Z","timestamp":1733194764000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Analysis of coinfections in patients with hematologic malignancies and COVID-19 by next-generation sequencing of bronchoalveolar lavage fluid"],"prefix":"10.1186","volume":"29","author":[{"given":"Wenxiu","family":"Shu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianqian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianqian","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liufei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanping","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingrong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaodong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dian","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,3]]},"reference":[{"issue":"2","key":"2180_CR1","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.21037\/apm-20-1863","volume":"10","author":"J Xie","year":"2021","unstructured":"Xie J, Wang Q, Xu Y, Zhang T, Chen L, Zuo X, et al. Clinical characteristics, laboratory abnormalities and CT findings of COVID-19 patients and risk factors of severe disease: a systematic review and meta-analysis. Ann Palliat Med. 2021;10(2):1928\u201349.","journal-title":"Ann Palliat Med"},{"issue":"5","key":"2180_CR2","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.4049\/jimmunol.1301152","volume":"191","author":"DW Metzger","year":"2013","unstructured":"Metzger DW, Sun K. Immune dysfunction and bacterial coinfections following influenza. J Immunol. 2013;191(5):2047\u201352.","journal-title":"J Immunol"},{"issue":"10","key":"2180_CR3","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1002\/iub.2356","volume":"72","author":"R Mirzaei","year":"2020","unstructured":"Mirzaei R, Goodarzi P, Asadi M, Soltani A, Aljanabi HAA, Jeda AS, et al. Bacterial co-infections with SARS-CoV-2. IUBMB Life. 2020;72(10):2097\u2013111.","journal-title":"IUBMB Life"},{"key":"2180_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/v9030058","author":"EA Almand","year":"2017","unstructured":"Almand EA, Moore MD, Jaykus LA. Virus-bacteria interactions: an emerging topic in human infection. Viruses. 2017. https:\/\/doi.org\/10.3390\/v9030058.","journal-title":"Viruses"},{"issue":"2","key":"2180_CR5","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jinf.2020.05.046","volume":"81","author":"L Lansbury","year":"2020","unstructured":"Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020;81(2):266\u201375.","journal-title":"J Infect"},{"issue":"9","key":"2180_CR6","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/cid\/ciaa530","volume":"71","author":"TM Rawson","year":"2020","unstructured":"Rawson TM, Moore LSP, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M, et al. Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020;71(9):2459\u201368.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"2180_CR7","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012560","volume":"12","author":"JA Bengoechea","year":"2020","unstructured":"Bengoechea JA, Bamford CG. SARS-CoV-2, bacterial co-infections, and AMR: the deadly trio in COVID-19? EMBO Mol Med. 2020;12(7): e12560.","journal-title":"EMBO Mol Med"},{"issue":"2","key":"2180_CR8","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/cid\/ciaa863","volume":"72","author":"M Fung","year":"2021","unstructured":"Fung M, Babik JM. COVID-19 in immunocompromised hosts: what we know so far. Clin Infect Dis. 2021;72(2):340\u201350.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2180_CR9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jinf.2021.01.029","volume":"82","author":"JM Peng","year":"2021","unstructured":"Peng JM, Du B, Qin HY, Wang Q, Shi Y. Metagenomic next-generation sequencing for the diagnosis of suspected pneumonia in immunocompromised patients. J Infect. 2021;82(4):22\u20137.","journal-title":"J Infect"},{"key":"2180_CR10","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2021.100906","volume":"53","author":"AM Casto","year":"2022","unstructured":"Casto AM, Fredricks DN, Hill JA. Diagnosis of infectious diseases in immunocompromised hosts using metagenomic next generation sequencing-based diagnostics. Blood Rev. 2022;53: 100906.","journal-title":"Blood Rev"},{"issue":"7","key":"2180_CR11","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1099\/jmm.0.000968","volume":"68","author":"C Qi","year":"2019","unstructured":"Qi C, Hountras P, Pickens CO, Walter JM, Kruser JM, Singer BD, et al. Detection of respiratory pathogens in clinical samples using metagenomic shotgun sequencing. J Med Microbiol. 2019;68(7):996\u20131002.","journal-title":"J Med Microbiol"},{"key":"2180_CR12","volume":"11","author":"Y Chen","year":"2021","unstructured":"Chen Y, Feng W, Ye K, Guo L, Xia H, Guan Y, et al. Application of metagenomic next-generation sequencing in the diagnosis of pulmonary infectious pathogens from bronchoalveolar lavage samples. Front Cell Infect Microbiol. 2021;11: 541092.","journal-title":"Front Cell Infect Microbiol"},{"issue":"6","key":"2180_CR13","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the eastern cooperative oncology group. Am J Clin Oncol. 1982;5(6):649\u201355.","journal-title":"Am J Clin Oncol"},{"issue":"6","key":"2180_CR14","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG, et al. An official American thoracic society\/European respiratory society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188(6):733\u201348.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"2180_CR15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4046\/trd.2018.0090","volume":"82","author":"SW Park","year":"2019","unstructured":"Park SW, Baek AR, Lee HL, Jeong SW, Yang SH, Kim YH, et al. Korean guidelines for diagnosis and management of interstitial lung diseases: part 1. Introduction. Tuberc Respir Dis (Seoul). 2019;82(4):269\u201376.","journal-title":"Tuberc Respir Dis (Seoul)"},{"issue":"2","key":"2180_CR16","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4046\/trd.2018.0091","volume":"82","author":"SH Lee","year":"2019","unstructured":"Lee SH, Yeo Y, Kim TH, Lee HL, Lee JH, Park YB, et al. Korean guidelines for diagnosis and management of interstitial lung diseases: part 2. Idiopathic Pulmonary Fibrosis. Tuberc Respir Dis (Seoul). 2019;82(2):102\u201317.","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"2180_CR17","unstructured":"Coronavirus Disease 2019 (COVID-19) treatment guidelines. Bethesda (MD) 2021."},{"issue":"9","key":"2180_CR18","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1164\/rccm.201202-0320ST","volume":"185","author":"KC Meyer","year":"2012","unstructured":"Meyer KC, Raghu G, Baughman RP, Brown KK, Costabel U, du Bois RM, et al. An official American thoracic society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med. 2012;185(9):1004\u201314.","journal-title":"Am J Respir Crit Care Med"},{"issue":"102","key":"2180_CR19","first-page":"33","volume":"19","author":"LS Cauley","year":"2015","unstructured":"Cauley LS, Vella AT. Why is coinfection with influenza virus and bacteria so difficult to control? Discov Med. 2015;19(102):33\u201340.","journal-title":"Discov Med"},{"issue":"11","key":"2180_CR20","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1080\/07391102.2020.1772110","volume":"39","author":"MA Hendaus","year":"2021","unstructured":"Hendaus MA, Jomha FA. Covid-19 induced superimposed bacterial infection. J Biomol Struct Dyn. 2021;39(11):4185\u201391.","journal-title":"J Biomol Struct Dyn"},{"issue":"12","key":"2180_CR21","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.cmi.2020.07.016","volume":"26","author":"BJ Langford","year":"2020","unstructured":"Langford BJ, So M, Raybardhan S, Leung V, Westwood D, MacFadden DR, et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020;26(12):1622\u20139.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"2180_CR22","doi-asserted-by":"crossref","first-page":"ofac037","DOI":"10.1093\/ofid\/ofac037","volume":"9","author":"G Satyanarayana","year":"2022","unstructured":"Satyanarayana G, Enriquez KT, Sun T, Klein EJ, Abidi M, Advani SM, et al. Coinfections in patients with cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) study. Open Forum Infect Dis. 2022;9(3):ofac037.","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"2180_CR23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13613-021-00873-x","volume":"11","author":"A Saade","year":"2021","unstructured":"Saade A, Moratelli G, Dumas G, Mabrouki A, Tudesq JJ, Zafrani L, et al. Infectious events in patients with severe COVID-19: results of a cohort of patients with high prevalence of underlying immune defect. Ann Intensiv Care. 2021;11(1):83.","journal-title":"Ann Intensiv Care"},{"issue":"4","key":"2180_CR24","first-page":"349","volume":"55","author":"SY Park","year":"2017","unstructured":"Park SY, Kim MY, Choi WJ, Yoon DH, Lee SO, Choi SH, et al. Pneumocystis pneumonia versus rituximab-induced interstitial lung disease in lymphoma patients receiving rituximab-containing chemotherapy. Med Mycol. 2017;55(4):349\u201357.","journal-title":"Med Mycol"},{"issue":"2","key":"2180_CR25","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00277-012-1592-1","volume":"92","author":"T Kim","year":"2013","unstructured":"Kim T, Choi SH, Kim SH, Jeong JY, Woo JH, Kim YS, et al. Point prevalence of pneumocystis pneumonia in patients with non-hodgkin lymphoma according to the number of cycles of R-CHOP chemotherapy. Ann Hematol. 2013;92(2):231\u20138.","journal-title":"Ann Hematol"},{"issue":"1","key":"2180_CR26","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1378\/chest.12-0477","volume":"144","author":"I Martin-Garrido","year":"2013","unstructured":"Martin-Garrido I, Carmona EM, Specks U, Limper AH. Pneumocystis pneumonia in patients treated with rituximab. Chest. 2013;144(1):258\u201365.","journal-title":"Chest"},{"issue":"Pt 7","key":"2180_CR27","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1099\/jmm.0.45528-0","volume":"53","author":"P Flori","year":"2004","unstructured":"Flori P, Bellete B, Durand F, Raberin H, Cazorla C, Hafid J, et al. Comparison between real-time PCR, conventional PCR and different staining techniques for diagnosing Pneumocystis Jiroveci pneumonia from bronchoalveolar lavage specimens. J Med Microbiol. 2004;53(Pt 7):603\u20137.","journal-title":"J Med Microbiol"},{"key":"2180_CR28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.phrs.2018.06.010","volume":"134","author":"S Brakemeier","year":"2018","unstructured":"Brakemeier S, Pfau A, Zukunft B, Budde K, Nickel P. Prophylaxis and treatment of Pneumocystis jirovecii pneumonia after solid organ transplantation. Pharmacol Res. 2018;134:61\u20137.","journal-title":"Pharmacol Res"},{"issue":"1","key":"2180_CR29","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13027-023-00556-1","volume":"18","author":"D Jin","year":"2023","unstructured":"Jin D, Le J, Yang Q, Cai Q, Dai H, Luo L, et al. Pneumocystis jirovecii with high probability detected in bronchoalveolar lavage fluid of chemotherapy-related interstitial pneumonia in patients with lymphoma using metagenomic next-generation sequencing technology. Infect Agent Cancer. 2023;18(1):80.","journal-title":"Infect Agent Cancer"},{"issue":"1","key":"2180_CR30","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1186\/s12879-022-07381-8","volume":"22","author":"P Lin","year":"2022","unstructured":"Lin P, Chen Y, Su S, Nan W, Zhou L, Zhou Y, et al. Diagnostic value of metagenomic next-generation sequencing of bronchoalveolar lavage fluid for the diagnosis of suspected pneumonia in immunocompromised patients. BMC Infect Dis. 2022;22(1):416.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"2180_CR31","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s10096-020-04063-8","volume":"40","author":"K Rothe","year":"2021","unstructured":"Rothe K, Feihl S, Schneider J, Wallnofer F, Wurst M, Lukas M, et al. Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship. Eur J Clin Microbiol Infect Dis. 2021;40(4):859\u201369.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"11","key":"2180_CR32","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1164\/rccm.202003-0543OC","volume":"201","author":"Y Du","year":"2020","unstructured":"Du Y, Tu L, Zhu P, Mu M, Wang R, Yang P, et al. Clinical features of 85 fatal cases of COVID-19 from Wuhan. A retrospective observational study. Am J Respir Crit Care Med. 2020;201(11):1372\u20139.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"2180_CR33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jhin.2017.12.008","volume":"99","author":"C Sticchi","year":"2018","unstructured":"Sticchi C, Alberti M, Artioli S, Assensi M, Baldelli I, Battistini A, et al. Regional point prevalence study of healthcare-associated infections and antimicrobial use in acute care hospitals in Liguria. Italy J Hosp Infect. 2018;99(1):8\u201316.","journal-title":"Italy J Hosp Infect"},{"issue":"1","key":"2180_CR34","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s13054-017-1803-1","volume":"21","author":"J Textoris","year":"2017","unstructured":"Textoris J, Mallet F. Immunosuppression and herpes viral reactivation in intensive care unit patients: one size does not fit all. Crit Care. 2017;21(1):230.","journal-title":"Crit Care"},{"issue":"2","key":"2180_CR35","volume":"9","author":"AH Walton","year":"2014","unstructured":"Walton AH, Muenzer JT, Rasche D, Boomer JS, Sato B, Brownstein BH, et al. Reactivation of multiple viruses in patients with sepsis. PLoS ONE. 2014;9(2): e98819.","journal-title":"PLoS ONE"},{"issue":"9","key":"2180_CR36","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/cid\/cix120","volume":"64","author":"DSY Ong","year":"2017","unstructured":"Ong DSY, Bonten MJM, Spitoni C, Verduyn Lunel FM, Frencken JF, Horn J, et al. Epidemiology of multiple herpes viremia in previously immunocompetent patients with septic shock. Clin Infect Dis. 2017;64(9):1204\u201310.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2180_CR37","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4103\/2319-4170.132905","volume":"38","author":"N Libert","year":"2015","unstructured":"Libert N, Bigaillon C, Chargari C, Bensalah M, Muller V, Merat S, et al. Epstein-Barr virus reactivation in critically ill immunocompetent patients. Biomed J. 2015;38(1):70\u20136.","journal-title":"Biomed J"},{"issue":"9","key":"2180_CR38","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s00296-022-05146-9","volume":"42","author":"S Zubchenko","year":"2022","unstructured":"Zubchenko S, Kril I, Nadizhko O, Matsyura O, Chopyak V. Herpesvirus infections and post-COVID-19 manifestations: a pilot observational study. Rheumatol Int. 2022;42(9):1523\u201330.","journal-title":"Rheumatol Int"},{"issue":"3","key":"2180_CR39","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.idnow.2021.01.005","volume":"51","author":"A Simonnet","year":"2021","unstructured":"Simonnet A, Engelmann I, Moreau AS, Garcia B, Six S, El Kalioubie A, et al. High incidence of Epstein-Barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically ill patients with COVID-19. Infect Dis Now. 2021;51(3):296\u20139.","journal-title":"Infect Dis Now"},{"key":"2180_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10060763","author":"JE Gold","year":"2021","unstructured":"Gold JE, Okyay RA, Licht WE, Hurley DJ. Investigation of long COVID prevalence and its relationship to epstein-barr virus reactivation. Pathogens. 2021. https:\/\/doi.org\/10.3390\/pathogens10060763.","journal-title":"Pathogens"},{"issue":"1","key":"2180_CR41","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13613-020-00706-3","volume":"10","author":"J Liu","year":"2020","unstructured":"Liu J, Zhang S, Wu Z, Shang Y, Dong X, Li G, et al. Clinical outcomes of COVID-19 in Wuhan, China: a large cohort study. Ann Intensiv Care. 2020;10(1):99.","journal-title":"Ann Intensiv Care"},{"issue":"5","key":"2180_CR42","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/joim.13231","volume":"289","author":"G Pomponio","year":"2021","unstructured":"Pomponio G, Ferrarini A, Bonifazi M, Moretti M, Salvi A, Giacometti A, et al. Tocilizumab in COVID-19 interstitial pneumonia. J Intern Med. 2021;289(5):738\u201346.","journal-title":"J Intern Med"},{"issue":"5","key":"2180_CR43","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00281-017-0629-x","volume":"39","author":"R Channappanavar","year":"2017","unstructured":"Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol. 2017;39(5):529\u201339.","journal-title":"Semin Immunopathol"},{"key":"2180_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens9030186","author":"HM Ashour","year":"2020","unstructured":"Ashour HM, Elkhatib WF, Rahman MM, Elshabrawy HA. Insights into the recent 2019 Novel Coronavirus (SARS-CoV-2) in light of past human coronavirus outbreaks. Pathogens. 2020. https:\/\/doi.org\/10.3390\/pathogens9030186.","journal-title":"Pathogens"},{"key":"2180_CR45","doi-asserted-by":"crossref","first-page":"3431612","DOI":"10.1155\/2023\/3431612","volume":"2023","author":"H Luoyi","year":"2023","unstructured":"Luoyi H, Yan P, Qihong F. Relationship between angiotensin-converting enzyme insertion\/deletion polymorphism and the risk of COVID-19: a meta-analysis. J Renin Angiotensin Aldosterone Syst. 2023;2023:3431612.","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"2180_CR46","doi-asserted-by":"crossref","first-page":"2549063","DOI":"10.1155\/2022\/2549063","volume":"2022","author":"E Schieffer","year":"2022","unstructured":"Schieffer E, Schieffer B. The race for ACE: targeting angiotensin-converting enzymes (ACE) in SARS-CoV-2 infection. J Renin Angiotensin Aldosterone Syst. 2022;2022:2549063.","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"4","key":"2180_CR47","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s40615-020-00853-0","volume":"8","author":"R Sarangarajan","year":"2021","unstructured":"Sarangarajan R, Winn R, Kiebish MA, Bountra C, Granger E, Narain NR. Ethnic prevalence of angiotensin-converting enzyme deletion (D) polymorphism and COVID-19 risk: rationale for use of angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers. J Racial Ethn Health Dispar. 2021;8(4):973\u201380.","journal-title":"J Racial Ethn Health Dispar"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-024-02180-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-024-02180-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-024-02180-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T02:59:37Z","timestamp":1733194777000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-024-02180-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,3]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2180"],"URL":"https:\/\/doi.org\/10.1186\/s40001-024-02180-0","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,3]]},"assertion":[{"value":"25 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethical Review Committee of Ningbo Medical Center Lihuili Hospital (approval No. YJZ2023SL2). The procedures used in this study adhere to the tenets of the Declaration of Helsinki. Informed consent was obtained from all subjects and\/or their legal guardian(s).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"576"}}